ISBT - In Focus

Scientific Programme per day

How viruses shape blood banking
Hepatitis C and blood banking the road to the nobel prize
Harvey Alter
SARS-CoV2 surveillance by blood banks: Variants, re-infections and vaccine-breakthrough infections
Ester Sabino
Blood donor Biobanks as a surveillance tool for future pandemics
Christian Erikstrup
MODERATOR: Mike Busch
14.00 CEST 
1 time zone only
General Assembly
ISBT members only

Opening Day

Roche satellite - Preparing for and responding to emerging infectious diseases

P-214 TRACKING SARS-COV-2 SEROPREVALENCE AMONG CANADIAN BLOOD DONORS THROUGH TWO PANDEMIC WAVESSahar Saeed
P-228 ASSOCIATION OF AGE WITH ANTI-SARS-COV-2 IGG ANTIBODY TITERS IN CONVALESCENT PLASMA DONORSEmma Castro
P-229 EVALUATION OF SARS-COV-2 ANTIBODY CONCENTRATIONS IN DIFFERENT CONVALESCENT PLASMA DONORS' SUBGROUPSRada Grubovic Rastvorceva
P-230 ASSESSMENT OF THE IMPACT OF PATHOGEN-INACTIVATION TREATMENT WITH THREE DIFFERENT COMMERCIALLY AVAILABLE TECHNOLOGIES ON THE ANTI-SARS-COV-2 N-PROTEIN IGG ANTIBODY TITER OF COVID-19 CONVALESCENT PLASMAFiodor Karpenka
P-233 PLASMA DONATED BY PERSONS VACCINATED AGAINST SARS-COV-2 IS NEW SOURCE FOR PASSIVE IMMUNOTHERAPYEugene Zhiburt
P-235 ESTABLISHMENT OF METHODOLOGY FOR COVID-19 CONVALESCENT PLASMA COLLECTION AND TESTING AT CROATIAN INSTITUTE OF TRANSFUSION MEDICINEAna Hećimović
P-226 ASSOCIATIONS BETWEEN SYMPTOMS, DONOR CHARACTERISTICS AND IGG ANTIBODY RESPONSE IN 2082 COVID-19 CONVALESCENT PLASMA DONORSMarieke Vinkenoog
P-246 EFFECT OF THE COVID-19 PANDEMIC ON BLOOD DONATION AND TRANSFUSION IN NIGERIA – A MULTI-FACILITY STUDY OF 34 TERTIARY HOSPITALSAdaeze Oreh
Immunohaematology – from routine to extreme
Genotyping & allele database 
William Lane
Challenges in the search for Rare Blood
Sandra Nance
The art of designing red cell panels and screens 
Erwin Scharberg
MODERATOR: Jill Storry
Interactive sessionPositive antibody screen - what next?! Case studies on everyday antibody ID 
 Interactive case studies with polling to demonstrate techniques and approaches to routine red cell antibody identification encountered in the hospital laboratory. 
 

Speakers
In first time zone (08.30 – 15.00 CEST): Thierry Peyrard / Nicole Thornton, Peter Ligthart, Brett Wilson
In second time zone (16.45 – 23.00 CEST): Thierry Peyrard / Nicole Thornton, Jan Hamilton, Cécile Toly-Ndour

Interactive sessionOpening the 'toolbox' to solve complex cases in reference laboratories
 Interactive case studies to explore the tools available (serological and molecular) for solving complex reference level immunohaematology cases.
 Speakers
In first time zone (08.30 – 15.00 CEST): Thierry Peyrard / Nicole Thornton, Vincent Thonier, Shane Grimsley
In second time zone (16.45 – 23.00 CEST): Thierry Peyrard / Nicole Thornton, Shane Grimsley, Vincent Thonier

Red Cell Immunohaematology

In first time zone (08.30 – 15.00 CEST):
GRIFOLS Red Cell Immunohematology Symposium - Real solutions to daily challenges in Transfusion Service laboratories

In second time zone (16.45 – 23.00 CEST):
IMMUCOR - Immucor as Strategic Partner for the daily challenges in Clinical Laboratory

P-024 COMPLETE REFERENCE SEQUENCES FOR ABO BLOOD GROUP GENE ALLELES BY LONG-READ SEQUENCINGMaja P. Mattle-Greminger
P-025 OPTIMISED DROPLET DIGITAL PCR APPROACH FOR NON-INVASIVE FOETAL BLOOD GROUP TYPING IN ALLO-IMMUNISED PREGNANT WOMENBarbera Veldhuisen
P-001 SEROLOGICAL EVIDENCES DEMONSTRATING THAT RHCE*CEMI (RHCE*03N.01) IS NOT A NULL ALLELEThierry Peyrard
P-002 ANTI-GIL IN AN INDIVIDUAL WITH A NOVEL AQP3 INACTIVATING MUTATION RESULTING IN THE RARE GIL− PHENOTYPE; A SEROLOGICAL AND MOLECULAR CASE STUDY WITH CLINICAL OUTCOME DATABenjamin Jones
P-027 AN EXAMPLE OF ANTI-CD99 IN AN ANTENATAL PATIENT WITH A NOVEL HOMOZYGOUS MUTATION IN CD99, RESULTING IN THE RARE CD99- PHENOTYPEAbigail Borowski
P-028 THE DNA SEQUENCE VARIATION AROUND THE INTRON 1 +5.8-KB SITE OF ABO GENE IS ASSOCIATED WITH ABO BLOOD TYPELei-Fang Tsai
P-029 A NOVEL KEL C.1414-1G>T ALLELE IDENTIFIED IN A POLISH PATIENT WITH ANTI-KU ANTIBODYMonika Pelc-Kłopotowska
P-003 IMPACT OF PROPHYLACTIC RED BLOOD CELL (RBC) TRANSFUSION WITH EXTENDED ANTIGEN MATCHING ON ALLOIMMUNIZATION IN PATIENTS WITH SICKLE CELL DISEASE (SCD)Ianca Leal

 

Platelets & Granulocyte immunobiology - On the trail of disease processes
Stored platelet extracellular vesicles and their role in TRALI induction
Mark J. McVey
A humanized animal model for understanding FNAIT 
Peter Newman
Serologic and molecular studies to identify neonatal alloimmune neutropenia in a cohort of 10,000 neonates
Larissa Lopes
MODERATOR: John Semple
Blood Products & Cellular Therapies - New questions on old problems
Are cold platelets here to stay? 
Andre Cap
Plasticizers, their needs and risks
Jason Acker
Update on platelet lysates and clinical usage
Thierry Burnouf
MODERATOR: Mickey Koh

 

 Platelet and Granulocyte Immunobiology
Interactive sessionPlatelet Immunobiology - how immune thrombocytopenias are investigated
 Case studies with interactive polling and Q&A to demonstrate how to recognise the importance of CD36 iso-immunization in Asian, African, South and Central American and Middle Eastern populations, trouble shoot and identify weaknesses with antigen-capture platelet antibody assays, and recognize the clinical features of Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT).
 In both time zones (08.30 – 15.00 CEST) / (16.45 – 23.00 CEST)
Organizers: Nelson Tsuno / Ulrich Sachs, Speaker: Brian Curtis, Moderators: Nuria Nogues, Lucie Richards, Gail Pahn, Veera Sekaran Nadarajan
Interactive sesionNeutrophil Immunobiology - how childhood immune neutropenias are investigated
 Case studies with interactive polling demonstrating diagnostic tools for autoimmune neutropenia in  infants, alloimmune neutropenia
 and drug dependent neutropenia.
 In both time zones (08.30 – 15.00 CEST) / (16.45 – 23.00 CEST)
Speakers: Behnaz Bayat, Brigitte Flesch, Brian Curtis
  Blood Products & Cellular Therapies
Interactive sessionFreezing rare donations; what's in your freezer?
 Presentations with interactive polling and discussions on:
- How to build a inventory of rare blood
- Criteria and methods for cryopreservation and use of frozen blood.
 In first time zone (08.30 – 15.00 CEST)
Organizer: Christine Lomas Francis, Speaker: Inna Sareneva, Dr. Yoshihiko Tani, Moderators: Tanya Powley, Vered Yahalom
In second time zone (16.45 – 23.00 CEST)
Organizer: Christine Lomas Francis, Speakers: Inna Sareneva Cinzia, Paccapelo, Moderator: Erwin Scharberg
Interactive sesionCAR-T cells: Growing Insights and New Developments
 Presentations interactive polling and discussions covering Cell Therapy; Leukemia; Lymphoma; Myeloma. 
Participants will learn Pivotal Results of Recent Clinical Studies using CAR-T Cells, New Avenues of Therapeutic Use of CAR-T Cells in Cancer and Pinciples of the GMP Manufacturing Process of CAR-T cells.
 In both time zones (08.30 – 15.00 CEST) / (16.45 – 23.00 CEST)
Organizer and Speaker: Mickey Koh, Reinhard Henschler

Platelets & Granulocyte Immunobiology
In first time zone (08.30 – 15.00 CEST):
Sponsored Session – Visit the Exhibition

In second time zone (16.45 – 23.00 CEST)
Sponsored Session – Visit the Exhibition

Blood Products & Cellular Therapies
In first time zone (08.30 – 15.00 CEST):
HEMANEXT - 10 min product demo

In second time zone (16.45 – 23.00 CEST)
Fresenius 10 min product demo

Platelets & Granulocyte Immunobiology 
P-153 CD8+FOXP3+ REGULATORY T CELLS DERIVED EXOSOMES ACT AS IMMUNE MODULATORS IN AUTOIMMUNE MODELYiming Yang
P-108 ENLARGING THROMBOCYTE DONOR POOL BY HLA IMPUTATION OF BIOBANK DATASatu Koskela
P-119 CXCR5+TREG CELLS INDUCED BY BAICALIN: ESTABLISHMENT OF INDUCTION/EXPANSION METHOD AND THE STUDY ON THEIR IMMUNOSUPPRESSIVE FUNCTION IN VITRO AND IN VIVOJie Yang
P-112 ASSOCIATION BETWEEN ABO BLOOD GROUPS AND AUTOIMMUNE NEUTROPENIA OF INFANCY IN DANISH PATIENTSKirstine Kloeve-Mogensen
P-113 A RETROSPECTIVE COHORT STUDY ON CASES SUPECTED OF FNAIT TO INVESTIGATE THE ASSOCIATION BETWEEN ANTI-HPA-5B ANTIBODIES AND THE OCCURRENCE OF CLINICAL FNAITThijs De Vos
P-114 THE CONUNDRUM OF MATERNAL HLA CLASS I ANTIBODIES AND NEONATAL THROMBOCYTOPENIA – A CASE REPORTBrigitte K. Flesch
Blood Products & Cellular Therapies 
P-071 BACTERIAL PROLIFERATION IN COLD-STORED PLATELET CONCENTRATESSandra Ramirez-Arcos
P-151 TRANSFUSION SUPPORT IN FIRST 100 DAYS OF ALLOGENEIC HSCTDivya Setya
P-051 FINNISH JK(A-B-) DONORS SUPPORTING ONCOLOGIC TREATMENT OF A US PATIENTInna Marleena Sareneva
P-264 ANTIOXIDANTS SUPPLEMENTATION EFFECTS ON RED BLOOD CELL STORAGE LESIONAlkmini Anastasiadi
P-265 IRREVERSIBLE PROCESSES IN THE CYTOSCELETON OF PACKED RED BLOOD CELLS DURING PROLONGED STORAGEEkaterina Sherstyukova
P-231 THE RESULTS OF HLA ANTIBODIES TESTING IN COVID-19 CONVALESCENT PLASMA FEMALE DONORS IN MOSCOW CITY BLOOD CENTERAnna Chumak
P-120 COMPREHENSIVE CHARACTERIZATION OF THE PHYSIOLOGY OF RED BLOOD CELLS FOLLOWING HYPOTONIC DIALYSIS-BASED DRUG ENCAPSULATION PROCESSMélanie Robert
P-279 COMPARISON OF FACTOR VIII ACTIVITY AT DIFFERENT STORAGE INTERVALS IN FRESH FROZEN PLASMA PRODUCED AT 8 HOURS AND 24 HOURS AFTER BLOOD DONATIONM H Yang
Never underestimate a virus!
Undisclosed HIV infections in HIV blood positive blood donors on ART therapy.
Marion Vermeulen
Is SARSCoV2 a threat to the blood supply? Impact of variants.
Pierre Cappy
SARS-CoV2 Vaccinations and their impact on blood services 
Susan Stramer/Roger Dodd
MODERATOR: Brian Custer

 

Interactive sessionTools, data needs and testing algorithms for blood supply safety monitoring
 Presentations interactive polling and discussions on monitoring new and old infectious threats and considerations on the framework for assessing if an agent is a TTID (general overview of the steps in the scientific process)
 In first time zone (08.30 – 15.00 CEST)
Speakers/moderators: Brian Custer, Katy Davison, Marion Vermeulen
In second time zone (16.45 – 23.00 CEST)
Speakers/moderators: Brian Custer, Sheila O'Brien
Interactive sessionApproaches for infectious disease diversity monitoring
 Interactive polling and discussions covering aproaches to infectious disease diversity monitoring including tools, testing and data needs.  Participants will learn about detecting or monitoring transfusion transmitted bacteria and transfusion transmitted virus diversity.
 In first time zone (08.30 – 15.00 CEST)
Speakers/moderators: Brian Custer, Carl McDonald, Daniel Candotti
In second time zone (16.45 – 23.00 CEST)
Speakers/moderators: Brian Custer, Sandra Ramirez-Arcos, Steve Drews

TTID

In first time zone (08.30 – 15.00 CEST):
GRIFOLS TTID Symposium - Strategies and Solutions to Mitigate HEV Risk in Blood Donations.

In second time zone (16.45 – 23.00 CEST)
Abbott Pandemic Defense Coalition - the Legacy and Future of Abbott Infectious Disease Research

P-072 EXPRESSION OF SUPERANTIGEN TOXIN GENES PRODUCED BY STAPHYLOCOCCUS AUREUS CULTURED IN PLATELET CONCENTRATES: GENOMIC AND TRANSCRIPTOMIC ANALYSESSylvia Ighem Chi
P-073 TESTING OF EXPIRED PLATELET CONCENTRATES FOR RESIDUAL BACTERIAL CONTAMINATIONLily Tang
P-075 THE MICROBIOME DISTRIBUTION CHARACTERISTICS OF THE WHOLE BLOOD AND APHERESIS PLATELET FROM HEALTHY DONORS BASED ON 16S RDNAYanling Ying
P-076 TRANSCRIPTOMIC ANALYSES REVEAL ENHANCED EXPRESSION OF VIRULENCE FACTORS BY A TRANSFUSION-TRANSMITTED STAPHYLOCOCCUS AUREUS STRAIN GROWN IN PLATELET CONCENTRATESBasit Yousuf
P-069 ACUTE PRIMARY OCCULT HEPATITIS B VIRUS INFECTION IN CHINESE REPEAT BLOOD DONORSDaniel Candotti
P-280 VALIDATION OF THE PREPARATION OF AMOTOSALEN/UVA LIGHT PATHOGEN REDUCED PLASMA FROM PREVIOUSLY QUARANTINED UNITSHervé Isola
P-081 HIGH LEVELS OF CONTAMINATING LIPIDS OR RED BLOOD CELLS DO NOT AFFECT THE INACTIVATION CAPACITY OF THE THERAFLEX UV-PLATELETS SYSTEMUte Gravemann
P-077 FURTHER ASSURANCE OF THE SAFETY OF BLOOD THROUGH THE ACCURATE DETECTION OF WEST NILE VIRUSClare Morris
You're never too old to be young
RBC transfusions in preterm neonates: Does hemoglobin type matter?
Luciana Teofili
TXA - where are we now 
Ciara Hanley
Red blood cell transfusion in older adults - what Hb threshold is suitable
Lin Fung
MODERATOR: Katerina Pavenski

 

 

Interactive sesssionNew advances in massive bleeding
 A case of a massively bleeding patient will be presented and the resuscitation strategy discussed interactively with the audience. Participants will learn how to use blood products in resuscitating massively bleeding patients and some of the new blood products that are available for use in this situation.
 In first time zone (08.30 – 15.00 CEST)
Organizers: Cynthia so Osman / Mark Yazer, speaker/moderator: Laura Green, speaker: Mansoor Khan
In second time zone (16.45 – 23.00 CEST)
Organizers: Cynthia so Osman / Mark Yazer, speaker/moderator: Mark Yazer, speaker: John Holcomb
Interactive sesssionThe patient with dyspnea after transfusion
 Interactive case studies of pulmonary transfusion reactions in both adult and peadiatric populations.
Participants will learn about the differential diagnosis of pulmonary transfusion reactions in adults, and how peadiatric patients may express symptoms of TACO and TRALI in a different ways.
 In first time zone (08.30 – 15.00 CEST)
Speakers: Mary Townsend, Gopal Patidar, moderator: Shruti Narayan
In second time zone (16.45 – 23.00 CEST)
Speaker: Kyle Annen, moderator: Mary Townsend

Clinical / Adverse Events

In first time zone (08.30 – 15.00 CEST):
Sponsored Session – Visit the Exhibition

In second time zone (16.45 – 23.00 CEST):
Sponsored Session – Visit the Exhibition

P-227 TRANSFUSION ADVERSE EVENTS ASSOCIATED WITH COVID-19 CONVALESCENT PLASMA COMPASSIONATE USE THERAPY FOR SARS-COV-2Anne-Marie Fillet
P-244 PROFILE OF COVID-19 PATIENTS THAT NEED BLOOD TRANSFUSIONPatricia Alcalde-Mellado
P-152 FACTORS AFFECTING RED CELL CONSUMPTION IN TRANSFUSION-DEPENDENT BETA-THALASSEMIA PATIENTSRoberto Reverberi
P-133 ALLERGIC REACTIONS LINKED TO IGA DEFICIENT PATIENTS: FACT OR FICTION?Catherine Sylvia Booth
P-140 OXIDATIVE STRESS GENE EXPRESSION PROFILE IN ENDOTHELIAL CELLS EXPOSED TO ADULT OR FETAL HEMOGLOBINNicoletta Orlando
P-134 TRANSFUSION REACTIONS IN ELDERLY UK PATIENTS 2015 - 2019Simon Carter-Graham
P-141 SURVEY ON NEONATAL TRANSFUSION PRACTICES IN 18 EUROPEAN COUNTRIESSusanna Fustolo-Gunnink
P-160 REGRESSION ANALYSIS TO PREDICT THE FACTOR VIII ACTIVITY OF HEMOPHILIA A PATIENTS WITHOUT INHIBITOR WHO RECEIVED EMICIZUMAB THERAPYYuki Hatayama
Supporting Safe Transfusion - It's all about the brain
What can AI do for you in transfusion medicine
Muhammed Mamdani
How transfusion practitioners use data to effect change 
Lise Estcourt
Strategies to eliminate errors in blood transfusions
Paula Bolton-Maggs
MODERATOR: Erica Wood
Strategic Management - Rules & Money
High level decision making on controversial issues 
Mindy Goldman
Mind the GAP – Sustainable Funding for Transfusion medicine in Low and Middle Income Countries
Karin van den Berg
How to succesfully campaign in transfusion medicine using social media 
TBA
MODERATOR: Ravi Reddy
 Supporting Safe Transfusion
Interactive session Incident Investigation
 Ineractive case studies to investigate causes of transfusion reactionsent reporting and investigation and show how to apply lessons learned from tehse investigations to improve transfusion practice. Participants will also
gain knowledge about the many freely available international resources for transfusion incident investigation and the significant role the TP can play in incident investigation.
 In both time zones (08.30 – 15.00 CEST) / (16.45 – 23.00 CEST)
Organizers: Linley Bielby / Rachel Moss, speaker/moderator: Jana vanden Broeck
Interactive session Audit and data for change
 An interactive exploration of a scenario of audit, data collection, analysis and reporting to support change management related to anaemia assessment in the surgical setting. 
Participants will learn how audit and data can be used to plan and implement change to improve blood management practice, gain knowledge about the freely available international resources to assist with audit, data collection and the significant role the TP can play in this.
 In both time zones (08.30 – 15.00 CEST) / (16.45 – 23.00 CEST)
Organizers: Linley Bielby / Rachel Moss, speaker/moderator: Jana vanden Broeck
 Strategic Management
Interactive session GMP / Quality systems for blood services
 Interactive session with discussion of the essentials of GP/GMP for blood and blood components and risk assessment using quality indicators in blood establishments. By following a real life case study, particpants will also learn about classification of non-compliances bassed on the (EuBIS Inspection Training Guide and Manual).
 In both time zones (08.30 – 15.00 CEST) / (16.45 – 23.00 CEST)
Speakers: Christian Seidl, Yan Qiu, Tomislav Vuk, Fewzi Teskrat, Jose Manuel Cardenas, moderators: Lesley Bust, Paul Strengers
Interactive session Managing traceability
 This interactive session will define traceability, discuss the importance of traceability to patient care, the risks inherent in record keeping that may result in a loss of traceability and provide an outline for an audit plan. Through two case studies, particpants will learn how to define the risks to the traceability chain of information and how to develop a traceability audit plan.
 In both time zones (08.30 – 15.00 CEST) / (16.45 – 23.00 CEST)
Speakers: Suzanne Butch, Paul Ashford

Supporting Safe Transfusion

In first time zone (08.30 – 15.00 CEST):
TERUMO bct Learn how IT connectivity enables Good Manufacturing Practices – Live tour at CRTS Valencia, Spain.

In second time zone (16.45 – 23.00 CEST)
Sponsored Session – Visit the Exhibition

Strategic Management

In first time zone (08.30 – 15.00 CEST):
Sponsored Session – Visit the Exhibition

In second time zone (16.45 – 23.00 CEST)
Sponsored Session – Visit the Exhibition

Supporting Safe Transfusion

 

P-173 PREVENTING ALLOIMMUNIZATION USING A NEW MODEL FOR MATCHING EXTENSIVELY TYPED RED BLOOD CELLSMerel L Wemelsfelder
P-161 AUDIT ON THE USE OF FIBRINOGEN CONCENTRATE WITHIN ICHNT MAJOR HAEMORRHAGE PROTOCOLSYee Man Tracy Hui
P-104 CURIOUS INCIDENTS IN THE NIGHT-TIME: LABORATORY ‘OUT OF HOURS’ AND LONE WORKING ERRORSVictoria Tuckley
P-103 SHIFTING THE PARADIGM TO IMPROVE SAFETYJennifer Davies
P-177 CMV SCREENING OF GROUP SPECIFIC ORDERS- GOOD STEWARDSHIPTara Francis
P-178 THE EFFECT OF COVID-19 ON BLOOD DONATION HABITSRichard Gammon
P-089 MAKING BLOOD SAFE THROUGH CENTRAL DEFERRAL REGISTRY: SUKUSAMohd Hazwan Ab Halim
P-097 IMPACT OF VARIOUS EDUCATIONAL STRATEGIES ON KNOWLEDGE AND PRACTICES OF CLINICIANS REGARDING BEDSIDE TRANSFUSION PRACTICESAnubhav Gupta

Strategic Management

 

P-078 COST-EFFECTIVENESS AND BUDGET IMPACT OF WHOLE BLOOD PATHOGEN REDUCTION IN GHANAW Alton Russell
P-245 THE IMPACT OF COVID-19 PANDEMIC ON YOUNG PROFESSIONALS IN TRANSFUSION MEDICINE: A GLOBAL PERSPECTIVEArwa Z. Al Riyami
P-215 CURRENT CHALLENGES OF SARS-COV-2 SEROPREVALENCE STUDIES AMONG BLOOD DONORS: A SCOPING REVIEWSahar Saeed
P-247 A SCOTTISH COLLABORATIVE EFFORT SUPPORTED BY NATIONAL DATA AND LOCAL INTELLIGENCE FROM CLINICAL AND LABORATORY TEAMS TO INFORM DEMAND PLANNING FOR BLOOD COMPONENTS DURING THE COVID-19 PANDEMICKatherine Forrester
P-255 COSTS AND OUTCOMES ASSOCIATED WITH LARGE VOLUME DELAYED SAMPLING AND PATHOGEN REDUCTION TECHNOLOGY PROCESSINGStephanie Earnshaw
P-086 TELEMEDICINE IN THE INSTITUTE FOR TRANSFUSION MEDICINE IN RNM – OUR EXPERIENCESadulla Useini
P-087 TRACEABILITY IMPACT OF A STANDARDRIZED UNIQUE IDENTIFIER FOR MEDICAL PRODUCTS OF HUMAN ORIGINKaren Moniz
P-175 AN ADAPTIVE APPROACH TO FORECASTING BLOOD DEMANDEsa Turkulainen
Let's hear it for Donors!
Managing Donors & Blood supply and sufficiency in India during COVID
Ratti Sharma
How can we redirect plasma?
Leni von Bonsdorff
Defending the rights of the donor
Alice Simonetti
World Blood  donor day
Vincenzo De Angelis
MODERATOR: Yuyun Maryuningsih

 

Interactive sessionInterventions to mitigate needle fear and donation anxiety 
 An intereactive discussion of factors contributing to needle fear and donation anxiety that can be related to the donor, to the donation system and staff. A mobile game to assist with this and  psychology of donation fear is discussed. Participants will learn how to recognise, manange and prevent needle fear and donor anxiety.
 In first time zone (08.30 – 15.00 CEST)
Organizer: Karin Magnussen, speakers: Elisabeth Huis in 't Veld, Judita Rudokaite, Eva- Maria Merz, moderator: Barbara Masser
In second time zone (16.45 – 23.00 CEST)
Organizer: Karin Magnussen, speakers: Elisabeth Huis in 't Veld, Judita Rudokaite, moderator: Eva- Maria Merz,
Interactive sessionDonor availability in the low resource environment, how can we deal with the challenges?
 Presentations and an interactive case study describing  the issues and practical solutions in the low-resource context. Round table discussions on the challenges of maintaining sufficient donors and donations with a panel of experts from different parts of the world.
 In both time zones (08.30 – 15.00 CEST) / (16.45 – 23.00 CEST)
Speakers: Martin Smid, Claude Tayou

 

Donors and Donation

In first time zone (08.30 – 15.00 CEST):
ABBOTT - Visit our booth!

In second time zone (16.45 – 23.00 CEST):
ROCHE - Donor Hero Initiative

P-184 A SIMPLE RECIPROCAL FAIRNESS MESSAGE ENHANCES NON-DONOR’S WILLINGNESS TO DONATE BLOODAbigail Edwards
P-186 THE POSTPONEMENT STUDY: A CLUSTER RANDOMISED TRIAL OF DEFERRAL EDUCATIONAL MATERIALS TO INCREASE DONOR RETURNCarley Nyssa Gemelli
P-185 INCREASING DONOR RETURN AFTER DEFERRAL: RESULTS FROM A FIELD RANDOMIZED CONTROLLED TRIAL TESTING ALTERNATIVE GOOD DEEDS AND ADDITIONAL INFORMATIONMarloes L.C. Spekman
P-198 AN ELECTRONIC DONOR HEALTH QUESTIONNAIRE MAY DECREASE BLOOD DONOR DEFERRAL RATEJohanna Castrén
P-232 COMPLICATIONS POST DONATION IN COVID-19 CONVALESCENT PLASMA DONORS – NHSBT EXPERIENCEShruthi Narayan
P-176 PREDICTION AND IMPACT OF PERSONALISED DONATION INTERVALSJarkko Toivonen
P-200 PRELIMINARY CHARACTERISATION OF BLOOD DONATION PRACTICES AND DONOR DEMOGRAPHICS IN SIX ASIAN REGIONSTakeshi Odajima
P-208 VALIDATION OF THE PREPARATION OF AMOTOSALEN/UVA LIGHT PATHOGEN REDUCED PLASMA FROM PREVIOUSLY QUARANTINED UNITSSurendra Karki